
South Sudan
Climate
Impact
News and Insights
In partnership with Buni Banda, AI Kenya and AMREF Health Africa, the Kenya Medical Research Institute has developed an AI-powered diagnosis assistant, designed to operate offline with microscopes in Kenyan public health laboratories. The aim is to reduce errors in tuberculosis diagnosis in rural areas with limited resources, thereby improving care for the most vulnerable patients.
Project ported by:


In Kenya, microscopy remains the most common method of diagnosis for tuberculosis and malaria, and is often the only option available in remote areas (MoH, 2020). However, the reliability of this technique is highly dependent on the healthcare professional's skills, workload, and the condition of equipment, particularly in peripheral laboratories, already under pressure and with scant resources, where the majority of diagnoses are made (Carter, 2016).
The limitations of microscopy in tuberculosis diagnosis have been well documented (Wongsrichanalai et al., 2007; Obare et al., 2013). In smear microscopy for tuberculosis, sensitivity varies from 20% to 80% depending on the reader's expertise, the quality of staining, and the bacillary load (Steingart et al., 2014).
This variability has direct repercussions for patients. A false negative delays life-saving care and prolongs the period of contagion, while a false positive exposes patients to unnecessary treatment and means that alternative diagnoses are missed. These errors result in preventable deaths and increase the financial burden on low-income families.
This project aims to provide a low-cost, fully offline, AI-powered device, used in complement with microscopes, to increase diagnosis accuracy in Kenyan public health laboratories where resources are scarce.
This innovative system offers several features that set it apart from existing solutions:
Once assembled, these components transform a standard microscope into an AI-powered microscope. No data transmission is required: the analysis is performed directly on a low-power device. During the preparation phase, the prototype will be tested and fine-tuned in ten pilot laboratories across six municipalities (Siaya, Busia, Kisumu, Vihiga, Homa Bay, and Migori), selected to cover the broad range of tuberculosis diagnosis conditions in Kenya.
Following the preparation phase, the consortium aims to demonstrate the solution's technical feasibility, acceptability, and potential deployment in Kenyan public laboratories. The project has three deliverables:
Projects
Projects funded by FID